Project information
Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
- Project Identification
- MSM0021622430
- Project Period
- 1/2007 - 12/2013
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- Research Intents
- MU Faculty or unit
- Faculty of Medicine
- Other MU Faculty/Unit
- Faculty of Science
- Other MU Faculty/Unit
- Faculty of Informatics
- Other MU Faculty/Unit
- Central European Institute of Technology
- Keywords
- embryonic stem cells
The goal of this project will be a) to profit from availability of unique cellular resources - mouse and human embryonic stem cells and normal and malignant hematopoietic stem/progenitor cells, b) to effectively employ a wide variety of current and complementary methodologies available to the consortium, and c) to exploit a proven/certified expertise in working with various living systems that span from in vitro cultured cells, through animal models to oncohematological patients. All this together will represent a powerful experimental platform aimed at addressing a nature of molecules and molecular mechanisms underlaying phenomena that are common to both normal and cancer stem cells, mainly their ability to self-renew and to enter differentiation pathways. Integral part of this general goal is to implement multifaceted analytical approach that will cover studies of gene expression at both mRNA and protein levels, evaluating function of extra and intracellular signaling pathways, and analyzing biological properties of cells in vitro and in vivo. Expected outcome will be not only understanding but also a definition of molecules and/or molecular pathways to be tested as therapeutic targets, and cellular models that will make such testing feasible.
Publications
Total number of publications: 360
2013
-
The Effect of Imatinib Treatment Duration on the Quality of the Life of Patients with Chronic Myeloid Leukemia
Journal of Blood Disorders & Transfusion, year: 2013, volume: 4, edition: 6, DOI
-
The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus
Leukemia Research, year: 2013, volume: 37, edition: 7, DOI
-
The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab
European Journal of Haematology, year: 2013, volume: 90, edition: 6, DOI
-
The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration
Cancer Research, year: 2013, volume: 73, edition: 5, DOI
-
The prospective analysis of low level BCR-ABL1 T315I mutation in the CD34+ cells of de novo CML patients
Year: 2013, type: Conference abstract
-
Tiam1 regulates the Wnt/Dvl/Rac1 signaling pathway and the differentiation of midbrain dopaminergic neurons.
Molecular and cellular biology, year: 2013, volume: 33, edition: 1, DOI
-
Vyhledávání a sledování klonů s mutací TP53 v chronické fázi myeloproliferativních neoplazií (MPN)
Year: 2013, type: Conference abstract
-
Whole-cell mass spectrometry profiling combined with artificial intelligence as a novel tool for fingerprinting of hESCs
Year: 2013, type: Appeared in Conference without Proceedings
-
Wnt-PCP pathway driving pathogenesis of chronic lymphocytic leukemia participates on normal B-cell development
Year: 2013, type: Conference abstract
2012
-
A real-time (PCR) for a real life ...? Quantitative evaluation of BCL2/IGH in follicular lymphoma and its implications for clinical practice
Experimental hematology, year: 2012, volume: 40, edition: 7, DOI